While we observed a 0.776% increase in methylation in PAH patients with no known PH gene mutation, relative to control subjects, there was a greater increase in methylation in the PAH TET2 group (1.124%), compared to healthy controls (Figure 1C). This evidence concerns the gene TET2 and pulmonary arterial hypertension.